August 14, 2007 / 10:27 AM / 10 years ago

Biolex files for $70 mln IPO

Aug 14 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc. said it filed with U.S. regulators to raise up to $70 million in an initial public offering of common stock. The Pittsboro, North Carolina-based company said it applied for listing on the Nasdaq under the symbol “BLEX”.

Lehman Brothers Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers, Biolex added. (Reporting by Esha Dey in Bangalore)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below